Clinical Trials Logo

Pulmonary Edema Cardiac Cause clinical trials

View clinical trials related to Pulmonary Edema Cardiac Cause.

Filter by:
  • None
  • Page 1

NCT ID: NCT05989139 Active, not recruiting - Clinical trials for Pulmonary Edema Cardiac Cause

HF vs NIV in Acute Cardiogenic Pulmonary Edema

HFvsNIV
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The study's primary aim is - to compare the effects of two different ventilation modalities, non-invasive positive-pressure ventilation (NPPV) and high-flow nasal cannulae (HFNC), in the acute cardiogenic pulmonary edema (ACPE) setting, in terms of echocardiographic parameters of RV systolic and RV strain. - to determine the differences of the two interventions on other hemodynamic parameters echocardiographically assessed. - to assess the differences between the two interventions on physiological parameters, i.e., mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), oxygen saturation (SpO2), and on arterial blood gases (ABG) analysis parameters (i.e. relief of dyspnea and respiratory distress, patient comfort). Enrolled patients will receive NPPV and HFNC oxygen therapy in a randomized, cross-over fashion, for 40 minutes each (time 0, T0 and time 1, T1), followed by clinical and echocardiographic evaluation

NCT ID: NCT04483843 Completed - Clinical trials for Pulmonary Edema Cardiac Cause

Cosmic Weather and Cardiogenic Pulmonary Edema

Start date: March 1, 2019
Phase:
Study type: Observational

Retrospective clinical study to evaluate whether there is any correlation between the pre-hospital incidence of cardiogenic pulmonary oedema (CPE) in the selected region and the space weather parameters.

NCT ID: NCT03936751 Suspended - Clinical trials for Obstructive Sleep Apnea

Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.

CPAP-CARE
Start date: April 1, 2019
Phase: Phase 4
Study type: Interventional

Despite the advances in the treatment of acute cardiogenic pulmonary edema (ACPE), the readmissions rates and cardiovascular events remain very high. In this context, it is possible that other potential risk factors may influence the poor prognosis of the ACPE. One of these potential candidates is Obstructive Sleep Apnea(OSA). This study was designed to evaluate the impact of OSA treatment with CPAP in consecutive patients with ACPE. The primary outcome will be to evaluate the impact of CPAP on the recurrence of ACPE in the 1-year follow-up.